<!-- This file corresponds to the Dose-Response Visualiser section of the page -->

<!DOCTYPE HTML>
<html lang="en">

<head>
	<meta charset="utf-8">
	<meta name="viewport" context="width=device-width, initial scale=1">
	<title>SPIKESfunc</title>

	<link rel="shortcut icon" href="images/favicon-196x196.png">
	<link rel="stylesheet" href="bootstrap/css/bootstrap.min.css">
	<link rel="stylesheet" href="css/button.css">
	<script src="plotly/plotly-latest.min.js"></script>
	<script src="bootstrap/js/jquery-3.3.1.min.js"></script>
	<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">


	<!-- Add in plotly.js files still to go, might put them in body -->

	<link href="css/stylesheet.css" rel="stylesheet">

</head>

<body>
	<!-- This is the header section of the page -->
	<header>
		<nav class="navbar navbar-light navbar-expand-lg fixed-top header">
			<div class="container">
				<a class="navbar-brand nav-style" href="index.html">
					<img src="images/favicon-196x196.png" width="30" height="30" class="d-inline-block align-center"
						alt="">
					SPIKES<i>func</i></a>
				<button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup"
					aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation">
					<span class="navbar-toggler-icon"></span>
				</button>
				<div class="collapse navbar-collapse" id="navbarNavAltMarkup">
					<ul class="navbar-nav ml-auto">
						<li class="nav-item">
							<a class="nav-item nav-link nav-style active" href="qualitative.html">Dose-Response
								Visualiser</a>
						</li>
						<li class="nav-item">
							<a class="nav-item nav-link nav-style" href="quantitative.html">Schild Plot Generator</a>
						</li>
						<li class="nav-item">
							<a class="nav-item nav-link nav-style" href="quiz.html">Schild Plot Analysis Quiz</a>
						</li>
						<li class="nav-item">
							<a class="nav-item nav-link nav-style" href="logtable.html"
								target="_blank">-logK<sub>i</sub> Values</a>
						</li>
					</ul>
				</div>
			</div>
		</nav>
	</header>

	<div id="loader"></div>

	<!-- This is the navbar section of the page where it has the Agonist Competitve Antagonist etc.. section -->
	<div id="page" class="container box-size bg-box p-4" style="visibility: hidden; position: absolute;">
		<h1 class="d-flex justify-content-center">Dose-Response Visualiser</h1>
		<p align="center">
			<button class="btn waves-effect waves-light red" onclick="showInstructionsQual()"><span
					class="fa fa-info-circle"></span> What to do?</button>
		</p>
		<br>
		<!-- The list of 6 different -->
		<ul class="nav nav-pills nav-justified" role="tablist">
			<li class="nav-item">
				<a class="nav-link active" data-toggle="tab" href="#home">Agonist</br></a>
			</li>
			<li class="nav-item">
				<a class="nav-link" data-toggle="tab" href="#menu1">Competitive Antagonist</a>
			</li>
			<li class="nav-item">
				<a class="nav-link" data-toggle="tab" href="#menu2">Irreversible Antagonist</a>
			</li>
			<li class="nav-item">
				<a class="nav-link" data-toggle="tab" href="#menu3">Allosteric Antagonist (Affinity)</a>
			</li>
			<li class="nav-item">
				<a class="nav-link" data-toggle="tab" href="#menu4">Allosteric Antagonist (Efficacy)</a>
			</li>
			<li class="nav-item">
				<a class="nav-link" data-toggle="tab" href="#menu5">Functional Antagonist</a>
			</li>
		</ul>


		<hr>
		<!-- This is the content below the visualisations -->
		<div class="tab-content">
			<div id="home" class="container tab-pane active">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top:50px">
							<a data-toggle="modal" href="" data-target="#whattodo1"
								class="btn waves-effect waves-light red" role="button"><span
									class="fa fa-info-circle"></span>&nbspAgonist</a>
							<div id="whattodo1" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<!-- The AGONIST button -->
										<div class="modal-header">
											<h4 class="modal-title">Agonist</h4>
										</div>
										<div class="modal-body">
											<!-- The contents once Agonist button is clicked -->
											<div class="box">
												<p>Observe the effects of changing the characteristics of the Agonist
													(affinity, intrinsic efficacy) and/or the Cell (receptor density,
													efficiency of coupling) by moving the red slider along the grey bar
													to the right or left to increase or decrease the value of the
													characteristic, respectively.</p>
												<img src="images/agonistchart.png" alt="Agonist Chart"
													style="max-height: 100%; max-width: 100%;" /><br />
												<p>Some clinically-used drugs act as agonists – e.g. salbutamol at the
													&#946<sub>2</sub>-adrenoceptor, adrenaline at various adrenoceptors,
													morphine at opioid receptors, etc.</p>
											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn waves-effect waves-light red"
												data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<!-- This is all the content inside the Aginist box -->
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info1"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info1" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Affinity</b> is a measure of the strength of binding of a drug
														to a receptor (both agonists and antagonists have affinity), and
														depends on the existence of chemical forces of attraction
														between the agonist and the receptor binding site (e.g. most
														commonly ionic bonds, hydrogen bonds, van der Waals forces). The
														strength of binding (affinity) depends upon the respective 3-D
														structures of the agonist and binding site – the strength of
														binding dissipates markedly as the distance between the agonist
														and binding site increases. High affinity agonists bind to
														binding sites at low concentrations, whereas low affinity
														agonists bind at higher concentrations. The affinity of ligands
														(agonists and antagonists) can be quantitated using the
														Equilibrium Dissociation Constant (K<sub>A</sub>), which is the
														concentration of ligand needed to occupy (bind to) 50% of
														receptors. K<sub>A</sub> is also the ratio of the rate the
														ligand (agonist or antagonist) leaves the receptor binding site
														(k<sub>off</sub>) and the rate it approaches the receptor
														binding site (k<sub>on</sub>). The K<sub>A</sub> value is
														inversely proportional to the affinity (high affinity ligands
														have low K<sub>A</sub> values) and is typically measured in drug
														binding assays (plots of [ligand] versus fractional receptor
														occupancy). As the [ligand] increases the fraction of receptor
														bound increases nonlinearly (rectangular hyperbolic function) to
														form a maximal asymptote (from which R<sub>T</sub> can be
														determined). Colloquially, “affinity is what brings the drug to
														the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="affslider" min="4" max="8"
									step="0.04" value="6" oninput="updateAffinity(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info2"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info2" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Intrinsic Efficacy</b> is the property of the agonist that
														enables it, once bound, to change the conformation of the
														receptor (activation), such that it alters the activity of
														downstream signalling pathways to produce a change in cellular
														activity. Efficacy is measured in relative terms, having no
														absolute scale – but different ligands have clearly different
														efficacies – full agonists have higher efficacies than partial
														agonists, and antagonists typically have no efficacy (bind to
														but don’t activate the receptor). Thus, different agonists have
														different inherent capacities to induce a response, and equal
														cellular responses can be achieved by different fractional
														receptor occupancies. Colloquially, efficacy is “what the drug
														does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficacy" id="effslider" min="-0.3"
									max="0.7" step="0.01" value="0.2" oninput="updateEfficacy(this.value)">
							</fieldset>

							<!-- The contents inside the Cell box -->
							<fieldset style="width: 430px;">
								<legend>Cell</legend>
								<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info3"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info3" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Receptor Density</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Receptor Density</b> is the total number of receptors,
														expressed in terms of unit area of membrane, or per cell, or per
														unit mass of protein. Proportional to the quantity
														B<sub>max</sub> (the maximal specific binding of a ligand, often
														expressed in units of mol ligand/mg protein, or ligands
														bound/cell) measured in radioligand binding studies. The
														relationship between B<sub>max</sub> and N is influenced by the
														number of ligand binding sites possessed by each receptor. For
														most receptors there is one binding site for the endogenous
														agonist, although for ligand-gated ion channels (e.g. nicotinic
														acetylcholine receptor), this is generally more than one.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="density" id="denslider" min="-0.3"
									max="0.7" step="0.01" value="0.2" oninput="updateDensity(this.value)">
								<br><label for="efficiency">Coupling Efficiency (<i>f</i>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info4"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info4" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Coupling Efficiency</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Coupling Efficiency</b> is a cell-dependent parameter
														describing the efficiency of the signalling pathways that couple
														(link) the activated receptor to the measured effect. Some cells
														have high coupling efficiencies, meaning that activation of a
														relatively small number of receptors can lead to a large
														cellular response. Other cells may have low coupling
														efficiencies (perhaps due to low expression / activity of a key
														signalling pathway component) and high levels of receptor
														activation may produce relatively small cellular responses.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficiency" id="efficislider" min="-0.3"
									max="0.7" step="0.01" value="0.2" oninput="updateEfficiency(this.value)">
							</fieldset>

							<!-- The contents inside the quiz box -->
							<fieldset style="width:430px;text-align:center">
								<legend>Questions</legend>
								<div id="agonistQuestion" style="margin-bottom:20px;"></div>
								<div id="restartMessageAgonist" style="display:none">There are no more questions. Would
									you like to try again?<br><br></div>

								<div id="agonistAnswerModal" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Answer</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<div id="agonistAnswer"></div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<button id="restartQuestionAgonist" style="display:none" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="restartQuestionAgonist()">Restart</button>
								<button id="prevAgonistQuestion" style="float:left" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="prevQuestionAgonist()">Previous Question</button>
								<button id="revealAgonistAnswer" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="revealAnswerAgonist()">Reveal Answer</button>
								<button id="nextAgonistQuestion" style="float:right" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="nextQuestionAgonist()">Next Question</button>
							</fieldset>

						</div>
						<!-- The Agonist box -->
						<div class="col-lg-7">
							<fieldset style="display:block">
								<legend>Agonist Dose Response Curve</legend>
								<h5 class="warning" id="agoalert"></h5>
								<div id="agonist"></div>
							</fieldset>
							<button id="reset" type="button" class="btn waves-effect waves-light red"
								onclick="resetAgo()" style="float: right;">Reset</button>
						</div>
					</div>
				</div>
			</div>

			<!-- This section relates to the Competitive Antagonist section -->
			<div id="menu1" class="container tab-pane fade">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top: 50px;">
							<a data-toggle="modal" href="" data-target="#whattodo2"
								class="btn waves-effect waves-light red" role="button"><span
									class="fa fa-info-circle"></span>&nbspCompetitive Antagonist</a>
							<div id="whattodo2" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<div class="modal-header">
											<h4 class="modal-title">Competitive Antagonist</h4>
										</div>
										<div class="modal-body">
											<div class="box">
												<p>Competitive antagonists bind reversibly to the same binding site on
													the receptor as the agonist (orthosteric binding). Thus, which
													molecule occupies the common binding site depends solely on the
													relative affinity and concentrations of the agonist and competitive
													antagonist. Thus, theoretically the [agonist] can be raised to the
													point that the concomitant receptor binding by the antagonist is
													minimal – at this point the maximum effect of the agonist will be
													observed, that is competitive antagonism is surmountable. The
													affinity of a competitive antagonist for a receptor can be
													determined from <b>binding</b> assays (saturation (K<sub>A</sub>)
													and/or competition binding (K<sub>i</sub>) assays using
													radioligands) and from <b>functional</b> assays (K<sub>B</sub>, by
													measuring the rightward shift of agonist dose-response curves in the
													presence of increasing [competitive antagonist] – Schild analysis).
													Although the constants <b>K<sub>A</sub>, K<sub>i</sub> and
														K<sub>B</sub></b> are determined using different experimental
													approaches, they each represent the affinity of the competitive
													antagonist for a receptor, and thus should have the <b>same molar
														value</b> (the concentration required to occupy 50% of
													receptors).</p>
												<img src="images/competitivechart.png" alt="Competitive Chart"
													style="max-height: 100%; max-width: 100%;" /><br />
												<p>The vast majority of clinically-used receptor antagonists are
													considered to act competitively – e.g. metoprolol at the
													&#946-adrenoceptor, atropine at the muscarinic cholinoceptor,
													losartan at the angiotensin AT1 receptor, etc.</p>
											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn waves-effect waves-light red"
												data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info5"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info5" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Affinity</b> is a measure of the strength of binding of a drug
														to a receptor (both agonists and antagonists have affinity), and
														depends on the existence of chemical forces of attraction
														between the agonist and the receptor binding site (e.g. most
														commonly ionic bonds, hydrogen bonds, van der Waals forces). The
														strength of binding (affinity) depends upon the respective 3-D
														structures of the agonist and binding site – the strength of
														binding dissipates markedly as the distance between the agonist
														and binding site increases. High affinity agonists bind to
														binding sites at low concentrations, whereas low affinity
														agonists bind at higher concentrations. The affinity of ligands
														(agonists and antagonists) can be quantitated using the
														Equilibrium Dissociation Constant (K<sub>A</sub>), which is the
														concentration of ligand needed to occupy (bind to) 50% of
														receptors. K<sub>A</sub> is also the ratio of the rate the
														ligand (agonist or antagonist) leaves the receptor binding site
														(k<sub>off</sub>) and the rate it approaches the receptor
														binding site (k<sub>on</sub>). The K<sub>A</sub> value is
														inversely proportional to the affinity (high affinity ligands
														have low K<sub>A</sub> values) and is typically measured in drug
														binding assays (plots of [ligand] versus fractional receptor
														occupancy). As the [ligand] increases the fraction of receptor
														bound increases nonlinearly (rectangular hyperbolic function) to
														form a maximal asymptote (from which R<sub>T</sub> can be
														determined). Colloquially, “affinity is what brings the drug to
														the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="affcomslider" min="4" max="8"
									step="0.04" value="6" oninput="updateAffinityCom(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info6"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info6" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Intrinsic Efficacy</b> is the property of the agonist that
														enables it, once bound, to change the conformation of the
														receptor (activation), such that it alters the activity of
														downstream signalling pathways to produce a change in cellular
														activity. Efficacy is measured in relative terms, having no
														absolute scale – but different ligands have clearly different
														efficacies – full agonists have higher efficacies than partial
														agonists, and antagonists typically have no efficacy (bind to
														but don’t activate the receptor). Thus, different agonists have
														different inherent capacities to induce a response, and equal
														cellular responses can be achieved by different fractional
														receptor occupancies. Colloquially, efficacy is “what the drug
														does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficacy" id="effcomslider" min="-0.3"
									max="0.7" step="0.01" value="0.2" oninput="updateEfficacyCom(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Cell</legend>
								<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info7"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info7" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Receptor Density</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Receptor Density</b> is the total number of receptors,
														expressed in terms of unit area of membrane, or per cell, or per
														unit mass of protein. Proportional to the quantity
														B<sub>max</sub> (the maximal specific binding of a ligand, often
														expressed in units of mol ligand/mg protein, or ligands
														bound/cell) measured in radioligand binding studies. The
														relationship between B<sub>max</sub> and N is influenced by the
														number of ligand binding sites possessed by each receptor. For
														most receptors there is one binding site for the endogenous
														agonist, although for ligand-gated ion channels (e.g. nicotinic
														acetylcholine receptor), this is generally more than one.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="density" id="dencomslider" min="-0.3"
									max="0.7" step="0.01" value="0.2" oninput="updateDensityCom(this.value)">
								<br><label for="efficiency">Coupling Efficiency (<i>f</i>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info8"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info8" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Coupling Efficiency</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Coupling Efficiency</b> is a cell-dependent parameter
														describing the efficiency of the signalling pathways that couple
														(link) the activated receptor to the measured effect. Some cells
														have high coupling efficiencies, meaning that activation of a
														relatively small number of receptors can lead to a large
														cellular response. Other cells may have low coupling
														efficiencies (perhaps due to low expression / activity of a key
														signalling pathway component) and high levels of receptor
														activation may produce relatively small cellular responses.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficiency" id="efficicomslider" min="-0.3"
									max="0.7" step="0.01" value="0.2" oninput="updateEfficiencyCom(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Competitive Antagonist</legend>
								<label for="agoaffinity">Affinity (&#8733 1/K<sub>B</sub>)&nbsp</label>
								<input type="range" autocomplete="off" name="agoaffinity" id="agoaffcomslider" min="7"
									max="11" step="0.04" value="9" oninput="updateAgoAffinityCom(this.value)"><br />
								<label for="antagocomp">-logK<sub>B</sub> =&nbsp</label>
								<input class="numbox" type="number" autocomplete="off" name="antagocomp" id="antagocomp"
									style="width: 60px;" readonly>
							</fieldset>
							<!--COLOURS OF DIFFERENT ONES-->
							<fieldset style="width:430px;text-align:center">
								<legend>Questions</legend>
								<div id="comQuestion" style="margin-bottom:20px;"></div>
								<div id="restartMessageCom" style="display:none">There are no more questions. Would you
									like to try again?<br><br></div>


								<div id="comAnswerModal" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Answer</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<div id="comAnswer"></div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<button id="restartQuestionCom" style="display:none" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="restartQuestionCom()">Restart</button>
								<button id="prevComQuestion" style="float:left" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="prevQuestionCom()">Previous Question</button>
								<button id="revealComAnswer" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="revealAnswerCom()">Reveal
									Answer</button>
								<button id="nextComQuestion" style="float:right" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="nextQuestionCom()">Next
									Question</button>
							</fieldset>

						</div>
						<div class="col-lg-7">
							<fieldset>
								<legend>Effect of a Competitive Antagonist on Agonist Dose Response Curve</legend>
								<h5 class="warning" id="comalert"></h5>
								<div id="competitive"></div>
							</fieldset>
							<button id="reset" type="button" class="btn waves-effect waves-light red"
								onclick="resetCom()" style="float: right;">Reset</button>
						</div>
					</div>
				</div>
			</div>

			<!-- This section relates to the Irreversible Antagonist -->
			<div id="menu2" class="container tab-pane fade">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top: 50px;">
							<a data-toggle="modal" href="" data-target="#whattodo3"
								class="btn waves-effect waves-light red" role="button"><span
									class="fa fa-info-circle"></span>&nbspIrreversible Antagonist</a>
							<div id="whattodo3" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<div class="modal-header">
											<h4 class="modal-title">Irreversible Antagonist</h4>
										</div>
										<div class="modal-body">
											<div class="box">
												<p>An irreversible antagonist binds <b>covalently</b> (not reversibly)
													to the same binding site on the receptor as the agonist (orthosteric
													binding), without activating the receptor. Such antagonists
													irreversibly inhibit agonist-induced responses, until new functional
													receptors are expressed by the cell. Irreversible antagonism is one
													form of non-competitive antagonism.</p>
												<img src="images/irreversiblechart.png" alt="Irreversible Chart"
													style="max-height: 100%; max-width: 100%;" /><br />
												<p>Relatively few clinically-used receptor antagonists are considered to
													act irreversibly – e.g. naloxazone at the opioid mu receptor,
													phenoxybenzamine at the &#945 adrenoceptor. Some drugs act
													‘pseudoirreversibly’ and occupy the orthosteric binding site for
													relatively long periods without forming a covalent bond e.g.
													tiotropium at the muscarinic cholinoceptor</p>
											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn waves-effect waves-light red"
												data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info9"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info9" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Affinity</b> is a measure of the strength of binding of a drug
														to a receptor (both agonists and antagonists have affinity), and
														depends on the existence of chemical forces of attraction
														between the agonist and the receptor binding site (e.g. most
														commonly ionic bonds, hydrogen bonds, van der Waals forces). The
														strength of binding (affinity) depends upon the respective 3-D
														structures of the agonist and binding site – the strength of
														binding dissipates markedly as the distance between the agonist
														and binding site increases. High affinity agonists bind to
														binding sites at low concentrations, whereas low affinity
														agonists bind at higher concentrations. The affinity of ligands
														(agonists and antagonists) can be quantitated using the
														Equilibrium Dissociation Constant (K<sub>A</sub>), which is the
														concentration of ligand needed to occupy (bind to) 50% of
														receptors. K<sub>A</sub> is also the ratio of the rate the
														ligand (agonist or antagonist) leaves the receptor binding site
														(k<sub>off</sub>) and the rate it approaches the receptor
														binding site (k<sub>on</sub>). The K<sub>A</sub> value is
														inversely proportional to the affinity (high affinity ligands
														have low K<sub>A</sub> values) and is typically measured in drug
														binding assays (plots of [ligand] versus fractional receptor
														occupancy). As the [ligand] increases the fraction of receptor
														bound increases nonlinearly (rectangular hyperbolic function) to
														form a maximal asymptote (from which R<sub>T</sub> can be
														determined). Colloquially, “affinity is what brings the drug to
														the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="affirrslider" min="4" max="8"
									step="0.04" value="6" oninput="updateAffinityIrr(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info10"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info10" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Intrinsic Efficacy</b> is the property of the agonist that
														enables it, once bound, to change the conformation of the
														receptor (activation), such that it alters the activity of
														downstream signalling pathways to produce a change in cellular
														activity. Efficacy is measured in relative terms, having no
														absolute scale – but different ligands have clearly different
														efficacies – full agonists have higher efficacies than partial
														agonists, and antagonists typically have no efficacy (bind to
														but don’t activate the receptor). Thus, different agonists have
														different inherent capacities to induce a response, and equal
														cellular responses can be achieved by different fractional
														receptor occupancies. Colloquially, efficacy is “what the drug
														does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficacy" id="effirrslider" min="-0.3"
									max="0.7" step="0.01" value="0.2" oninput="updateEfficacyIrr(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Cell</legend>
								<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info11"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info11" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Receptor Density</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Receptor Density</b> is the total number of receptors,
														expressed in terms of unit area of membrane, or per cell, or per
														unit mass of protein. Proportional to the quantity
														B<sub>max</sub> (the maximal specific binding of a ligand, often
														expressed in units of mol ligand/mg protein, or ligands
														bound/cell) measured in radioligand binding studies. The
														relationship between B<sub>max</sub> and N is influenced by the
														number of ligand binding sites possessed by each receptor. For
														most receptors there is one binding site for the endogenous
														agonist, although for ligand-gated ion channels (e.g. nicotinic
														acetylcholine receptor), this is generally more than one.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="density" id="denirrslider" min="-0.3"
									max="0.7" step="0.01" value="0.2" oninput="updateDensityIrr(this.value)">
								<br><label for="efficiency">Coupling Efficiency (<i>f</i>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info12"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info12" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Coupling Efficiency</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Coupling Efficiency</b> is a cell-dependent parameter
														describing the efficiency of the signalling pathways that couple
														(link) the activated receptor to the measured effect. Some cells
														have high coupling efficiencies, meaning that activation of a
														relatively small number of receptors can lead to a large
														cellular response. Other cells may have low coupling
														efficiencies (perhaps due to low expression / activity of a key
														signalling pathway component) and high levels of receptor
														activation may produce relatively small cellular responses.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficiency" id="efficiirrslider" min="-0.3"
									max="0.7" step="0.01" value="0.2" oninput="updateEfficiencyIrr(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Irreversible Antagonist</legend>
								<label for="agoaffinity">Affinity (&#8733 1/K<sub>B</sub>)&nbsp</label>
								<input type="range" autocomplete="off" name="agoaffinity" id="agoaffirrslider" min="7"
									max="11" step="0.04" value="9" oninput="updateAgoAffinityIrr(this.value)"><br />
								<label for="antagoirr">-logK<sub>B</sub> =&nbsp</label>
								<input class="numbox" type="number" autocomplete="off" name="antagoirr" id="antagoirr"
									style="width: 60px;" readonly>
							</fieldset>
							<fieldset style="width:430px; text-align:center">
								<legend>Questions</legend>
								<div id="irrQuestion" style="margin-bottom:20px;"></div>
								<div id="restartMessageIrr" style="display:none">There are no more questions. Would you
									like to try again?<br><br></div>


								<div id="irrAnswerModal" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Answer</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<div id="irrAnswer"></div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<button id="restartQuestionIrr" style="display:none" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="restartQuestionIrr()">Restart</button>
								<button id="prevIrrQuestion" style="float:left" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="prevQuestionIrr()">Previous Question</button>
								<button id="revealIrrAnswer" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="revealAnswerIrr()">Reveal
									Answer</button>
								<button id="nextIrrQuestion" style="float:right" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="nextQuestionIrr()">Next
									Question</button>
							</fieldset>
						</div>
						<div class="col-lg-7">
							<fieldset>
								<legend>Effect of an Irreversible Antagonist on Agonist Dose Response Curve</legend>
								<h5 class="warning" id="irralert"></h5>
								<div id="irreversible"></div>
							</fieldset>
							<button id="reset" type="button" class="btn waves-effect waves-light red"
								onclick="resetIrr()" style="float: right;">Reset</button>
						</div>
					</div>
				</div>
			</div>

			<!-- This section relates to Allosteric Antagonist -->
			<div id="menu3" class="container tab-pane fade">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top: 50px;">
							<a data-toggle="modal" href="" data-target="#whattodo4"
								class="btn waves-effect waves-light red" role="button"><span
									class="fa fa-info-circle"></span>&nbspAllosteric Antagonist</a>
							<div id="whattodo4" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<div class="modal-header">
											<h4 class="modal-title">Allosteric Antagonist (Affinity)</h4>
										</div>
										<div class="modal-body">
											<div class="box">
												<p>Allosteric antagonists bind reversibly to receptors, without
													activating the receptor, at a site that is <b>different</b> from the
													agonist binding site. Allosteric antagonists reduce agonist affinity
													&/or efficacy, thereby inhibiting agonist-induced effects. They are
													also referred to as negative allosteric modulators (NAMs). Unlike
													competitive antagonists, the effects of an allosteric antagonist are
													saturable – this is because once the allosteric site is saturated,
													there are no further allosteric effects on the agonist. Allosteric
													antagonism is another form of non-competitive antagonism, as a
													receptor can bind both the agonist and the allosteric antagonist
													simultaneously.</p>
												<img src="images/allostericchart.png" alt="Affinity Chart"
													style="max-height: 100%; max-width: 100%;" /><br />
												<p>Relatively few clinically-used receptor antagonists are considered to
													act as negative allosteric modulators although this is an active
													area of research, e.g. maraviroc at the CCR5 receptor is an
													allosteric antagonist. In contrast, drugs such as the
													benzodiazepines act as positive allosteric modulators and enhance
													the binding affinity of the agonist</p>
											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn waves-effect waves-light red"
												data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info13"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info13" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Affinity</b> is a measure of the strength of binding of a drug
														to a receptor (both agonists and antagonists have affinity), and
														depends on the existence of chemical forces of attraction
														between the agonist and the receptor binding site (e.g. most
														commonly ionic bonds, hydrogen bonds, van der Waals forces). The
														strength of binding (affinity) depends upon the respective 3-D
														structures of the agonist and binding site – the strength of
														binding dissipates markedly as the distance between the agonist
														and binding site increases. High affinity agonists bind to
														binding sites at low concentrations, whereas low affinity
														agonists bind at higher concentrations. The affinity of ligands
														(agonists and antagonists) can be quantitated using the
														Equilibrium Dissociation Constant (K<sub>A</sub>), which is the
														concentration of ligand needed to occupy (bind to) 50% of
														receptors. K<sub>A</sub> is also the ratio of the rate the
														ligand (agonist or antagonist) leaves the receptor binding site
														(k<sub>off</sub>) and the rate it approaches the receptor
														binding site (k<sub>on</sub>). The K<sub>A</sub> value is
														inversely proportional to the affinity (high affinity ligands
														have low K<sub>A</sub> values) and is typically measured in drug
														binding assays (plots of [ligand] versus fractional receptor
														occupancy). As the [ligand] increases the fraction of receptor
														bound increases nonlinearly (rectangular hyperbolic function) to
														form a maximal asymptote (from which R<sub>T</sub> can be
														determined). Colloquially, “affinity is what brings the drug to
														the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="affaffslider" min="4" max="8"
									step="0.04" value="6" oninput="updateAffinityAff(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info14"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info14" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Intrinsic Efficacy</b> is the property of the agonist that
														enables it, once bound, to change the conformation of the
														receptor (activation), such that it alters the activity of
														downstream signalling pathways to produce a change in cellular
														activity. Efficacy is measured in relative terms, having no
														absolute scale – but different ligands have clearly different
														efficacies – full agonists have higher efficacies than partial
														agonists, and antagonists typically have no efficacy (bind to
														but don’t activate the receptor). Thus, different agonists have
														different inherent capacities to induce a response, and equal
														cellular responses can be achieved by different fractional
														receptor occupancies. Colloquially, efficacy is “what the drug
														does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficacy" id="effaffslider" min="-0.3"
									max="0.7" step="0.01" value="0.2" oninput="updateEfficacyAff(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Cell</legend>
								<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info15"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info15" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Receptor Density</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Receptor Density</b> is the total number of receptors,
														expressed in terms of unit area of membrane, or per cell, or per
														unit mass of protein. Proportional to the quantity
														B<sub>max</sub> (the maximal specific binding of a ligand, often
														expressed in units of mol ligand/mg protein, or ligands
														bound/cell) measured in radioligand binding studies. The
														relationship between B<sub>max</sub> and N is influenced by the
														number of ligand binding sites possessed by each receptor. For
														most receptors there is one binding site for the endogenous
														agonist, although for ligand-gated ion channels (e.g. nicotinic
														acetylcholine receptor), this is generally more than one.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="density" id="denaffslider" min="-0.3"
									max="0.7" step="0.01" value="0.2" oninput="updateDensityAff(this.value)">
								<br><label for="efficiency">Coupling Efficiency (<i>f</i>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info16"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info16" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Coupling Efficiency</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Coupling Efficiency</b> is a cell-dependent parameter
														describing the efficiency of the signalling pathways that couple
														(link) the activated receptor to the measured effect. Some cells
														have high coupling efficiencies, meaning that activation of a
														relatively small number of receptors can lead to a large
														cellular response. Other cells may have low coupling
														efficiencies (perhaps due to low expression / activity of a key
														signalling pathway component) and high levels of receptor
														activation may produce relatively small cellular responses.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficiency" id="efficiaffslider" min="-0.3"
									max="0.7" step="0.01" value="0.2" oninput="updateEfficiencyAff(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Allosteric Antagonist</legend>
								<label for="agoaffinity">Affinity (&#8733 1/K<sub>B</sub>)&nbsp</label>
								<input type="range" autocomplete="off" name="agoaffinity" id="agoaffslider" min="7"
									max="11" step="0.04" value="9" oninput="updateAgoAffinityAff(this.value)"><br>
								<label for="antagoaff">-logK<sub>B</sub> =&nbsp</label>
								<input class="numbox" type="number" autocomplete="off" name="antagoaff" id="antagoaff"
									style="width: 60px;" readonly>
								<br><label for="effect">Cooperativity Factor (&#945)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info17"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info17" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Cooperativity Factor</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p>The <b>Cooperativity Factor &#945</b> indicates the maximum
														effect produced by the allosteric antagonist on agonist affinity
														– a value of 0.1 indicates that the allosteric antagonist can
														produce up to a 10-fold reduction in agonist affinity. Observe
														the effects of changing the affinity and/or cooperativity factor
														(&#945) of the Allosteric Antagonist on the shape and position
														of the Agonist dose-response curve by moving the red slider
														along the grey bar to the right or left to increase or decrease
														the value of the characteristic, respectively.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="effect" id="agoeffaffslider" min="0"
									max="2" step="0.001" value="1" oninput="updateAgoEffectAff(this.value)">
								<br />
								<label for="antcoopaff">&#945 =&nbsp</label>
								<input class="numbox" type="number" autocomplete="off" name="antcoopaff" id="antcoopaff"
									readonly>
							</fieldset>
							<fieldset style="width:430px;text-align:center">
								<legend>Questions</legend>
								<div id="affQuestion" style="margin-bottom:20px"></div>
								<div id="restartMessageAff" style="display:none">There are no more questions. Would you
									like to try again?<br><br></div>

								<div id="affAnswerModal" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Answer</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<div id="affAnswer"></div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<button id="restartQuestionAff" style="display:none" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="restartQuestionAff()">Restart</button>
								<button id="prevAffQuestion" style="float:left" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="prevQuestionAff()">Previous Question</button>
								<button id="revealAffAnswer" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="revealAnswerAff()">Reveal
									Answer</button>
								<button id="nextAffQuestion" style="float:right" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="nextQuestionAff()">Next
									Question</button>
							</fieldset>

						</div>
						<div class="col-lg-7">
							<fieldset>
								<legend>Effect of an Allosteric Antagonist on Agonist Dose Response Curve</legend>
								<h5 class="warning" id="affalert"></h5>
								<div id="alloaffin"></div>
							</fieldset>
							<button id="reset" type="button" class="btn waves-effect waves-light red"
								onclick="resetAff()" style="float: right;">Reset</button>
						</div>
					</div>
				</div>
			</div>

			<!-- Allosteric Antagonist Efficacy -->
			<div id="menu4" class="container tab-pane fade">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top: 50px;">
							<a data-toggle="modal" href="" data-target="#whattodo5"
								class="btn waves-effect waves-light red" role="button"><span
									class="fa fa-info-circle"></span>&nbspAllosteric Antagonist</a>
							<div id="whattodo5" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<div class="modal-header">
											<h4 class="modal-title">Allosteric Antagonist (Efficacy)</h4>
										</div>
										<div class="modal-body">
											<div class="box">
												<p>Allosteric antagonists bind reversibly to receptors, without
													activating the receptor, at a site that is different from the
													agonist binding site. Allosteric antagonists reduce agonist affinity
													&/or efficacy, thereby inhibiting agonist-induced effects. They are
													also referred to as negative allosteric modulators (NAMs). Unlike
													competitive antagonists, the effects of an allosteric antagonist are
													saturable – this is because once the allosteric site is saturated,
													there are no further allosteric effects on the agonist. Allosteric
													antagonism is another form of non-competitive antagonism, as a
													receptor can bind both the agonist and the allosteric antagonist
													simultaneously.</p>
												<img src="images/allostericchart.png" alt="Efficacy Chart"
													style="max-height: 100%; max-width: 100%;" />
											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn waves-effect waves-light red"
												data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info18"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info18" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Affinity</b> is a measure of the strength of binding of a drug
														to a receptor (both agonists and antagonists have affinity), and
														depends on the existence of chemical forces of attraction
														between the agonist and the receptor binding site (e.g. most
														commonly ionic bonds, hydrogen bonds, van der Waals forces). The
														strength of binding (affinity) depends upon the respective 3-D
														structures of the agonist and binding site – the strength of
														binding dissipates markedly as the distance between the agonist
														and binding site increases. High affinity agonists bind to
														binding sites at low concentrations, whereas low affinity
														agonists bind at higher concentrations. The affinity of ligands
														(agonists and antagonists) can be quantitated using the
														Equilibrium Dissociation Constant (K<sub>A</sub>), which is the
														concentration of ligand needed to occupy (bind to) 50% of
														receptors. K<sub>A</sub> is also the ratio of the rate the
														ligand (agonist or antagonist) leaves the receptor binding site
														(k<sub>off</sub>) and the rate it approaches the receptor
														binding site (k<sub>on</sub>). The K<sub>A</sub> value is
														inversely proportional to the affinity (high affinity ligands
														have low K<sub>A</sub> values) and is typically measured in drug
														binding assays (plots of [ligand] versus fractional receptor
														occupancy). As the [ligand] increases the fraction of receptor
														bound increases nonlinearly (rectangular hyperbolic function) to
														form a maximal asymptote (from which R<sub>T</sub> can be
														determined). Colloquially, “affinity is what brings the drug to
														the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="affeffslider" min="4" max="8"
									step="0.04" value="6" oninput="updateAffinityEff(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info19"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info19" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Intrinsic Efficacy</b> is the property of the agonist that
														enables it, once bound, to change the conformation of the
														receptor (activation), such that it alters the activity of
														downstream signalling pathways to produce a change in cellular
														activity. Efficacy is measured in relative terms, having no
														absolute scale – but different ligands have clearly different
														efficacies – full agonists have higher efficacies than partial
														agonists, and antagonists typically have no efficacy (bind to
														but don’t activate the receptor). Thus, different agonists have
														different inherent capacities to induce a response, and equal
														cellular responses can be achieved by different fractional
														receptor occupancies. Colloquially, efficacy is “what the drug
														does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<input type="range" autocomplete="off" name="efficacy" id="effeffslider" min="-0.3"
									max="0.7" step="0.01" value="0.2" oninput="updateEfficacyEff(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Cell</legend>
								<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info20"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info20" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Receptor Density</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Receptor Density</b> is the total number of receptors,
														expressed in terms of unit area of membrane, or per cell, or per
														unit mass of protein. Proportional to the quantity
														B<sub>max</sub> (the maximal specific binding of a ligand, often
														expressed in units of mol ligand/mg protein, or ligands
														bound/cell) measured in radioligand binding studies. The
														relationship between B<sub>max</sub> and N is influenced by the
														number of ligand binding sites possessed by each receptor. For
														most receptors there is one binding site for the endogenous
														agonist, although for ligand-gated ion channels (e.g. nicotinic
														acetylcholine receptor), this is generally more than one.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="density" id="deneffslider" min="-0.3"
									max="0.7" step="0.01" value="0.2" oninput="updateDensityEff(this.value)">
								<br><label for="efficiency">Coupling Efficiency (<i>f</i>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info21"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info21" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Coupling Efficiency</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Coupling Efficiency</b> is a cell-dependent parameter
														describing the efficiency of the signalling pathways that couple
														(link) the activated receptor to the measured effect. Some cells
														have high coupling efficiencies, meaning that activation of a
														relatively small number of receptors can lead to a large
														cellular response. Other cells may have low coupling
														efficiencies (perhaps due to low expression / activity of a key
														signalling pathway component) and high levels of receptor
														activation may produce relatively small cellular responses.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficiency" id="efficieffslider" min="-0.3"
									max="0.7" step="0.01" value="0.2" oninput="updateEfficiencyEff(this.value)">
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Allosteric Antagonist</legend>
								<label for="agoaffinity">Affinity (&#8733 1/K<sub>B</sub>)&nbsp</label>
								<input type="range" autocomplete="off" name="agoaffinity" id="agoaffeffslider" min="7"
									max="11" step="0.04" value="9" oninput="updateAgoAffinityEff(this.value)"><br />
								<label for="antagoeff">-logK<sub>B</sub> =&nbsp</label>
								<input class="numbox" type="number" autocomplete="off" name="antagoeff" id="antagoeff"
									style="width: 60px;" readonly>
								<br><label for="effect">Cooperativity Factor (&#946)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info22"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info22" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Cooperativity Factor</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p>The <b>Cooperativity Factor &#946</b> indicates the maximum
														effect produced by the allosteric antagonist on agonist
														efficacy. Observe the effects of changing the affinity and/or
														cooperativity factor (&#946) of the Allosteric Antagonist on the
														shape and position of the Agonist dose-response curve by moving
														the red slider along the grey bar to the right or left to
														increase or decrease the value of the characteristic,
														respectively.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="effect" id="agoeffeffslider" min="0"
									max="2" step="0.001" value="1" oninput="updateAgoEffectEff(this.value)"><br />
								<label for="antcoopeff">&#946 =&nbsp</label>
								<input class="numbox" type="number" autocomplete="off" name="antcoopeff" id="antcoopeff"
									style="width: 65px;" readonly>
							</fieldset>
							<fieldset style="width:430px;text-align:center">
								<legend>Questions</legend>
								<div id="effQuestion" style="margin-bottom:20px"></div>
								<div id="restartMessageEff" style="display:none">There are no more questions. Would you
									like to try again?<br><br></div>


								<div id="effAnswerModal" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Answer</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<div id="effAnswer"></div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<button id="restartQuestionEff" style="display:none" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="restartQuestionEff()">Restart</button>
								<button id="prevEffQuestion" style="float:left" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="prevQuestionEff()">Previous Question</button>
								<button id="revealEffAnswer" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="revealAnswerEff()">Reveal
									Answer</button>
								<button id="nextEffQuestion" style="float:right" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="nextQuestionEff()">Next
									Question</button>
							</fieldset>
						</div>
						<div class="col-lg-7">
							<fieldset>
								<legend>Effect of an Allosteric Antagonist on Agonist Dose Response Curve</legend>
								<h5 class="warning" id="effalert"></h5>
								<div id="alloeffic"></div>
							</fieldset>
							<button id="reset" type="button" class="btn waves-effect waves-light red"
								onclick="resetEff()" style="float: right;">Reset</button>
						</div>
					</div>
				</div>
			</div>

			<!-- This section corresponds to the Functional Antagonist -->
			<div id="menu5" class="container tab-pane fade">
				<div class="col col-lg-12">
					<div class="row">
						<div class="col-lg-5" style="padding-top: 5px;">
							<a data-toggle="modal" href="" data-target="#whattodo6"
								class="btn waves-effect waves-light red" role="button"><span
									class="fa fa-info-circle"></span>&nbspFunctional Antagonist</a>
							<div id="whattodo6" class="modal fade" role="dialog">
								<div class="modal-dialog">
									<div class="modal-content">
										<div class="modal-header">
											<h4 class="modal-title">Functional Antagonist</h4>
										</div>
										<div class="modal-body">
											<div class="box">
												<p>Functional antagonists are agonists that produce a functional effect
													in the cell that is the opposite of that produced by another agonist
													(e.g. agonist A constricts smooth muscle, whereas agonist B relaxes
													smooth muscle). The net effect produced depends upon the relative
													properties of the respective agonists (affinity & efficacy) and
													their signalling pathways (R<sub>T</sub> & coupling efficiency).</p>
												<img src="images/functionalchart.png" alt="Functional Chart"
													style="max-height: 100%; max-width: 100%;" /><br />
												<p>An example of a functional antagonist would be salbutamol, which by
													activating &#946<sub>2</sub>-adrenoceptors on airway smooth muscle
													and producing relaxation can functionally antagonise airway smooth
													muscle contraction induced by a wide array of spasmogenic agonists
													including acetylcholine, histamine and leukotrienes, each acting
													through their own specific receptors.</p>
											</div>
										</div>
										<div class="modal-footer">
											<button type="button" class="btn waves-effect waves-light red"
												data-dismiss="modal">Close</button>
										</div>
									</div>
								</div>
							</div>
							<fieldset style="width: 430px;">
								<legend>Agonist</legend>
								<label for="affinity">Affinity (&#8733 1/K<sub>A</sub>)&nbsp</label><a
									data-toggle="modal" href="" data-target="#info23"><i
										class="red1 fa fa-info-circle"></i></a>
								<div id="info23" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Affinity</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Affinity</b> is a measure of the strength of binding of a drug
														to a receptor (both agonists and antagonists have affinity), and
														depends on the existence of chemical forces of attraction
														between the agonist and the receptor binding site (e.g. most
														commonly ionic bonds, hydrogen bonds, van der Waals forces). The
														strength of binding (affinity) depends upon the respective 3-D
														structures of the agonist and binding site – the strength of
														binding dissipates markedly as the distance between the agonist
														and binding site increases. High affinity agonists bind to
														binding sites at low concentrations, whereas low affinity
														agonists bind at higher concentrations. The affinity of ligands
														(agonists and antagonists) can be quantitated using the
														Equilibrium Dissociation Constant (K<sub>A</sub>), which is the
														concentration of ligand needed to occupy (bind to) 50% of
														receptors. K<sub>A</sub> is also the ratio of the rate the
														ligand (agonist or antagonist) leaves the receptor binding site
														(k<sub>off</sub>) and the rate it approaches the receptor
														binding site (k<sub>on</sub>). The K<sub>A</sub> value is
														inversely proportional to the affinity (high affinity ligands
														have low K<sub>A</sub> values) and is typically measured in drug
														binding assays (plots of [ligand] versus fractional receptor
														occupancy). As the [ligand] increases the fraction of receptor
														bound increases nonlinearly (rectangular hyperbolic function) to
														form a maximal asymptote (from which R<sub>T</sub> can be
														determined). Colloquially, “affinity is what brings the drug to
														the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="affinity" id="afffunslider" min="4" max="8"
									step="0.04" value="6" oninput="updateAffinityFun(this.value)">
								<br><label for="efficacy">Intrinsic Efficacy (&#949)&nbsp</label><a data-toggle="modal"
									href="" data-target="#info24"><i class="red1 fa fa-info-circle"></i></a>
								<div id="info24" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Intrinsic Efficacy</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<p><b>Intrinsic Efficacy</b> is the property of the agonist that
														enables it, once bound, to change the conformation of the
														receptor (activation), such that it alters the activity of
														downstream signalling pathways to produce a change in cellular
														activity. Efficacy is measured in relative terms, having no
														absolute scale – but different ligands have clearly different
														efficacies – full agonists have higher efficacies than partial
														agonists, and antagonists typically have no efficacy (bind to
														but don’t activate the receptor). Thus, different agonists have
														different inherent capacities to induce a response, and equal
														cellular responses can be achieved by different fractional
														receptor occupancies. Colloquially, efficacy is “what the drug
														does once it binds to the receptor”.</p>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>
								<input type="range" autocomplete="off" name="efficacy" id="efffunslider" min="0"
									max="0.6667" step="0.006667" value="0.33335"
									oninput="updateEfficacyFun(this.value)">
								<fieldset>
									<legend>Cell</legend>
									<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label><a
										data-toggle="modal" href="" data-target="#info25"><i
											class="red1 fa fa-info-circle"></i></a>
									<div id="info25" class="modal fade" role="dialog">
										<div class="modal-dialog">
											<div class="modal-content">
												<div class="modal-header">
													<h4 class="modal-title">Receptor Density</h4>
												</div>
												<div class="modal-body">
													<div class="box">
														<p><b>Receptor Density</b> is the total number of receptors,
															expressed in terms of unit area of membrane, or per cell, or
															per unit mass of protein. Proportional to the quantity
															B<sub>max</sub> (the maximal specific binding of a ligand,
															often expressed in units of mol ligand/mg protein, or
															ligands bound/cell) measured in radioligand binding studies.
															The relationship between B<sub>max</sub> and N is influenced
															by the number of ligand binding sites possessed by each
															receptor. For most receptors there is one binding site for
															the endogenous agonist, although for ligand-gated ion
															channels (e.g. nicotinic acetylcholine receptor), this is
															generally more than one.</p>
													</div>
												</div>
												<div class="modal-footer">
													<button type="button" class="btn waves-effect waves-light red"
														data-dismiss="modal">Close</button>
												</div>
											</div>
										</div>
									</div>
									<input type="range" autocomplete="off" name="density" id="denfunslider" min="0"
										max="0.6667" step="0.006667" value="0.33335"
										oninput="updateDensityFun(this.value)">
									<br><label for="efficiency">Coupling Efficiency (<i>f</i>)&nbsp</label><a
										data-toggle="modal" href="" data-target="#info26"><i
											class="red1 fa fa-info-circle"></i></a>
									<div id="info26" class="modal fade" role="dialog">
										<div class="modal-dialog">
											<div class="modal-content">
												<div class="modal-header">
													<h4 class="modal-title">Coupling Efficiency</h4>
												</div>
												<div class="modal-body">
													<div class="box">
														<p><b>Coupling Efficiency</b> is a cell-dependent parameter
															describing the efficiency of the signalling pathways that
															couple (link) the activated receptor to the measured effect.
															Some cells have high coupling efficiencies, meaning that
															activation of a relatively small number of receptors can
															lead to a large cellular response. Other cells may have low
															coupling efficiencies (perhaps due to low expression /
															activity of a key signalling pathway component) and high
															levels of receptor activation may produce relatively small
															cellular responses.</p>
													</div>
												</div>
												<div class="modal-footer">
													<button type="button" class="btn waves-effect waves-light red"
														data-dismiss="modal">Close</button>
												</div>
											</div>
										</div>
									</div>
									<input type="range" autocomplete="off" name="efficiency" id="efficifunslider"
										min="0" max="0.6667" step="0.006667" value="0.33335"
										oninput="updateEfficiencyFun(this.value)">
								</fieldset>
							</fieldset>
							<fieldset style="width: 430px;">
								<legend>Functional Antagonist</legend>
								<label for="agoaffinity">Affinity (&#8733 1/K<sub>B</sub>)&nbsp</label>
								<input type="range" autocomplete="off" name="agoaffinity" id="agoafffunslider" min="6"
									max="10" step="0.04" value="8" oninput="updateAgoAffinityFun(this.value)">
								<br><label for="effect">Intrinsic Efficacy (&#949)&nbsp</label>
								<input type="range" autocomplete="off" name="effect" id="agoefffunslider" min="-0.6667"
									max="0" step="0.06667" value="-0.33335" oninput="updateAgoEfficacyFun(this.value)">
								<!--value was -0.216-->
								<fieldset>
									<legend>Cell</legend>
									<label for="density">Receptor Density (R<sub>T</sub>)&nbsp</label>
									<input type="range" autocomplete="off" name="density" id="agodenfunslider"
										min="-0.6667" max="0" step="0.006667" value="-0.33335"
										oninput="updateAgoDensityFun(this.value)">
									<!--value was -0.216-->
									<br><label for="efficiency">Coupling Efficiency (<i>f</i>)&nbsp</label>
									<input type="range" autocomplete="off" name="efficiency" id="agoefficifunslider"
										min="-0.6667" max="0" step="0.06667" value="-0.33335"
										oninput="updateAgoEfficiencyFun(this.value)">
									<!--value was -0.216-->
								</fieldset>
							</fieldset>
							<fieldset style="width:430px;text-align:center">
								<legend>Questions</legend>
								<div id="funQuestion" style="margin-bottom:20px;"></div>
								<div id="restartMessageFun" style="display:none">There are no more questions. Would you
									like to try again?<br><br></div>


								<div id="funAnswerModal" class="modal fade" role="dialog">
									<div class="modal-dialog">
										<div class="modal-content">
											<div class="modal-header">
												<h4 class="modal-title">Answer</h4>
											</div>
											<div class="modal-body">
												<div class="box">
													<div id="funAnswer"></div>
												</div>
											</div>
											<div class="modal-footer">
												<button type="button" class="btn waves-effect waves-light red"
													data-dismiss="modal">Close</button>
											</div>
										</div>
									</div>
								</div>

								<button id="restartQuestionFun" style="display:none" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="restartQuestionFun()">Restart</button>
								<button id="prevFunQuestion" style="float:left" type="button"
									class="btn waves-effect waves-light red qbutton"
									onclick="prevQuestionFun()">Previous Question</button>
								<button id="revealFunAnswer" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="revealAnswerFun()">Reveal
									Answer</button>
								<button id="nextFunQuestion" style="float:right" type="button"
									class="btn waves-effect waves-light red qbutton" onclick="nextQuestionFun()">Next
									Question</button>
							</fieldset>
						</div>
						<div class="col-lg-7" style="padding-top: 40px;">
							<fieldset>
								<legend>Effect of a Functional Antagonist on Agonist Dose Response Curve</legend>
								<h5 class="warning" id="funalert"></h5>
								<div id="functional"></div>
							</fieldset>
							<button id="reset" type="button" class="btn waves-effect waves-light red"
								onclick="resetFun()" style="float: right;">Reset</button>
						</div>
					</div>
				</div>
			</div>
		</div>
	</div>


	</div>
	</div>

	<!-- The following are the javascript files  -->
	<script type="text/javascript" src="js/script.js"></script>
	<script type="text/javascript" src="js/scriptcom.js"></script>
	<script type="text/javascript" src="js/scriptirr.js"></script>
	<script type="text/javascript" src="js/scriptaff.js"></script>
	<script type="text/javascript" src="js/scripteff.js"></script>
	<script type="text/javascript" src="js/scriptfun.js"></script>
	<script src="bootstrap/js/jquery-3.3.1.min.js"></script>
	<script src="bootstrap/js/bootstrap.bundle.min.js"></script>
	<script src='https://cdnjs.cloudflare.com/ajax/libs/d3/3.4.13/d3.min.js'></script>
	<script src='https://cdnjs.cloudflare.com/ajax/libs/trianglify/0.1.5/trianglify.min.js'></script>
	<script type="text/javascript" src="js/triangle.js"></script>


	<!-- The footer with their content  -->
	<footer id="footer" class="footer" style="visibility: hidden;">
		<div class="container">
			<ul class="list-inline">
				<li class="list-inline-item">
					<a class="foot-titles" data-toggle="modal" href="" data-target="#about">About</a>
				</li>
				<li class="footer-menu-divider list-inline-item">⋅</li>
				<li class="list-inline-item">
					<a class="foot-titles" data-toggle="modal" href="" data-target="#instructions">Instructions</a>
				</li>
				<li class="footer-menu-divider list-inline-item">⋅</li>
				<li class="list-inline-item">
					<a class="foot-titles" data-toggle="modal" href="" data-target="#contact">Contact</a>
				</li>
			</ul>
			<p class="cc text-muted small">Creative Commons &copy; 2018 </p>
		</div>
		<div id="about" class="modal fade" role="dialog">
			<div class="modal-dialog">
				<div class="modal-content">
					<div class="modal-header">
						<h4 class="modal-title">About</h4>
					</div>
					<div class="modal-body">
						<p><b>Summary about the project</b><br />Agonists produce effects in cells by activating
							receptors and downstream signalling pathways. This app contains an interactive “Dose
							Response Visualiser” which allows users to alter agonist-dependent factors (affinity,
							intrinsic efficacy) and/or cell-dependent factors (receptor density, coupling efficiency)
							and observe in real time how this changes the agonist dose-response
							relationship.<br /><br />Agonist-induced effects can be blocked by drugs called antagonists,
							which are amongst the most widely used class of drug in medicine. There exist many different
							types of antagonists, named on the basis of how they block the agonist-induced effect:
							competitive, irreversible, allosteric and functional antagonists. Within the “Dose Response
							Visualiser”, users can observe the different patterns of effect produced by each of these
							antagonists (and the influence of antagonist concentrations and affinity) on the agonist
							dose-response relationship.<br /><br />Quantitative analysis of the effect of competitive
							antagonists on agonist-induced effects is a powerful method for identifying the receptors
							that mediate agonist-induced effects (Schild analysis), and is used in drug discovery and
							receptor characterisation. The app contains a “Schild Plot Generator”, where users can
							select the properties of agonists and antagonists and generate Schild Plots, and work
							through a series of theoretical questions and experimental scenarios that build proficiency
							and enhance understanding of key Schild concepts.<br /><br />These newly developed
							proficiencies and understandings can then be tested using the “Schild Analysis Quiz” tool
							within the app, were users are provided with a series of Schild Plots obtained to 5
							antagonists acting on a single receptor subtype within a common cell, and users are
							challenged to analyse each of the Schild Plots using the SPIKES approach to deduce which
							single receptor subtype is mediating the agonist-induced response. Feedback is provided for
							each of the literally 1000s of different quiz questions.<br /><br />Thus, SPIKESfunc is an
							interactive, educational application that boosts proficiency in the interpretation of
							functional pharmacological data through the visual and quantitative analysis of agonist and
							antagonist dose-response relationships. SPIKESfunc can be used in conjunction with
							SPIKESbind (or SPIKESmate), a complementary interactive educational app designed to enhance
							the proficiency in the interpretation of binding pharmacological data.<br /><br />The
							SPIKESfunc application was created by Cameron Turner, Daniel Brown, Harry Brooker and Thai
							Nguyen, undergraduate students of the Professional Computing unit (CITS3200) at The
							University of Western Australia, as directed by Associate Professor Peter Henry of the
							Division of Pharmacology, School of Biomedical Sciences, UWA.</p>
						<p><b>References</b></p>
						<p> - Black JW, Leff P. (1983) Operational models of pharmacological agonism. Proc R Soc Lond B
							Biol Sci. 220(1219):141-62.<br /><br />
							- Christopoulos A, Kenakin T (2002) G protein-coupled receptor allosterism and complexing.
							Pharmacol Rev. 54(2):323-74.<br /><br />
							- Christopoulos A (2014) Advances in G protein-coupled receptor allostery: from function to
							structure. Mol Pharmacol. 86(5):463-78. <br /><br />
							- Ehlert FJ. (2015) Functional studies cast light on receptor states. Trends Pharmacol Sci.
							36(9):596-604.<br /><br />
							- Kenakin, T.P. (2004) A Pharmacology Primer: Theory, Application, and Methods. First Edn.
							Elsevier Academic Press, San Diego, CA, USA.<br /><br />
							- Kenakin T. (2006) Data-driven analysis in drug discovery. J Recept Signal Transduct Res.
							26(4):299-327.<br /><br />
							- Kenakin T, Jenkinson S, Watson C. (2006) Determining the potency and molecular mechanism
							of action of insurmountable antagonists. J Pharmacol Exp Ther. 319(2):710-23.<br /><br />
							- Kenakin T, Watson C, Muniz-Medina V, Christopoulos A, Novick S. (2012) A simple method for
							quantifying functional selectivity and agonist bias. ACS Chem Neurosci.
							3(3):193-203.<br /><br />
							- Kenakin T. (2017) A Scale of Agonism and Allosteric Modulation for Assessment of
							Selectivity, Bias, and Receptor Mutation. Mol Pharmacol 92(4):414-424.<br /><br />
							- Keov P, Sexton PM, Christopoulos A (2011) Allosteric modulation of G protein-coupled
							receptors: a pharmacological perspective. Neuropharmacology 60(1):24-35.<br /><br />
							- Leff P, Martin GR, Morse JM. (1985) Application of the operational model of agonism to
							establish conditions when functional antagonism may be used to estimate agonist dissociation
							constants. Br J Pharmacol. 85(3):655-63.<br /><br />
							- Lew MJ (1995) Extended concentration-response curves used to reflect full agonist
							efficacies and receptor occupancy-response coupling ranges. Br J Pharmacol.
							115(5):745-52.<br /><br />
							- Neubig RR, Spedding M, Kenakin T, Christopoulos A; International Union of Pharmacology
							Committee on Receptor Nomenclature and Drug Classification. (2003) International Union of
							Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on
							terms and symbols in quantitative pharmacology. Pharmacol Rev. 55(4):597-606.<br /><br />
							- Offermeier J, van den Brink FG. (1974) The antagonism between cholinomimetic agonists and
							beta-adrenoceptor stimulants. The differentiation between functional and metaffinoid
							antagonism. Eur J Pharmacol. 27(2):206-13.<br /><br />
							- van den Brink FG (1973) The model of functional interaction. I. Development and first
							check of a new model of functional synergism and antagonism. Eur J Pharmacol.
							22(3):270-8.<br /><br />
							- van den Brink FG. (1973) The model of functional interaction. II. Experimental
							verification of a new model: the antagonism of beta-adrenoceptor stimulants and other
							agonists. Eur J Pharmacol. 22(3):279-86.<br /><br />
							- Wyllie DJ, Chen PE. (2007) Taking the time to study competitive antagonism. Br J
							Pharmacol. 150(5):541-51.</p>
					</div>
					<div class="modal-footer">
						<button type="button" class="btn waves-effect waves-light red"
							data-dismiss="modal">Close</button>
					</div>
				</div>
			</div>
		</div>
		<div id="instructions" class="modal fade" role="dialog">
			<div class="modal-dialog modal-lg">
				<div class="modal-content">
					<div class="modal-header">
						<h4 class="modal-title">Instructions</h4>
					</div>
					<div class="modal-body">
						<ul class="nav nav-tabs nav-pills nav-justified" role="tablist">
							<li class="nav-item">
								<a class="nav-link active" data-toggle="tab" href="#qual">Dose-Response
									Visualiser</br></a>
							</li>
							<li class="nav-item">
								<a class="nav-link" data-toggle="tab" href="#quant">Schild Plot Generator</a>
							</li>
							<li class="nav-item">
								<a class="nav-link" data-toggle="tab" href="#quizz">Schild Plot Analysis Quiz</a>
							</li>
						</ul>
					</div>
					<div class="tab-content">
						<div id="qual" class="container tab-pane active">
							<div class="col col-lg-12">
								<p><span style="color:Red">Agonists</span> bind to and activate receptors to induce
									changes in the activity of the receptor-expressing
									cells – a simple schematic of this process can be seen by clicking the <span
										style="color:red">red <span class="fa fa-info-circle"></span> Agonist</span>
									icon. The
									magnitude of these agonist-induced changes in cell activity are dependent on the
									concentration of
									the agonist, and are typically displayed using agonist dose-response curves (see
									default sigmoid-
									shaped Agonist Dose-Response Curve).
								</p>
								<p>
									Agonist dose response curves provide important information regarding:
								</p>
								<p>
									<b>1.</b> The maximum level of effect (response) induced by the highest
									concentrations of agonist
									(expressed as a percentage of the maximum change in cell activity, %Emax), and
								</p>
								<p>
									<b>2.</b> The potency of the agonist, which is the concentration of the agonist
									producing a particular level
									of effect (response), usually expressed as the molar concentration of agonist
									producing 50% of the
									agonist’s maximum response (EC<sub>50</sub> value).
								</p>
								<p>
									The shape and position of agonist dose-response curves depend upon the properties of
									both the
									agonist (affinity and intrinsic efficacy) and the cell (receptor density and the
									coupling efficiency).
									Specific information about these parameters can be obtained by clicking the <span
										style="color:red">red <span class="fa fa-info-circle"></span> icons</span>.
								</p>
								<p>
									Relative values for the four agonist and cell parameters are represented by red
									sliders, and can be
									changed by moving the sliders to the left (to decrease parameter value) or to the
									right (to increase
									parameter value) along the grey bar. Thus, this agonist dose-response visualiser
									enables you to
									visualise how the position and shape of the agonist dose-response curve changes in
									response to
									increases or decreases in agonist affinity or efficacy or in cell receptor density
									or coupling efficiency.
								</p>
								<p>
									You can enhance your understanding of these key concepts of agonism by working
									through a series
									of Questions (see Questions window) that encourage the use of the Dose-Response
									Visualiser (see
									the ‘Question’ window). An Answer to each of the Questions posed can be obtained by
									clicking on
									the Reveal Answer icon.
								</p>
								<p>
									<span style="color:red">Antagonists</span> bind to receptors and inhibit
									agonist-induced responses. There exist different classes of
									antagonists, including Competitive antagonists, Irreversible antagonists, Allosteric
									antagonists and
									Functional antagonists. As their names suggest, these different classes of
									antagonist interact with
									the receptors in distinct ways, and likewise affect agonist dose-response curves in
									characteristic
									ways – thus each class of antagonist has its own visualiser. Further information
									about each of these
									classes of antagonists can be obtained by clicking the <span style="color:red">red
										<span class="fa fa-info-circle"></span> Antagonist</span> icon in each specific
									window.
									The magnitude of inhibitory effects produced by an antagonist depends upon both the
									concentration and affinity of the antagonist. By default, the effects produced by 1,
									10, 100 and 1000
									nM concentrations of antagonist on the agonist dose-response curves are displayed in
									red. The
									effect of changing the affinity of the antagonist on these effects can also be
									visualised by moving the
									red sliders in the Antagonist window to the left (to decrease antagonist affinity)
									or to the right (to
									increase antagonist affinity) along the grey bar. The extent to which the actions of
									the antagonist
									is dependent on the characteristics of the agonist (affinity, intrinsic efficacy)
									and/or cell (receptor
									density, coupling efficiency) can also be displayed by moving the appropriate
									sliders in the Agonist or
									Cell windows.
								</p>
								<p>
									A return to default parameter values can be accomplished by clicking on the
									<b>RESET</b> button.
								</p>
								<p>
									You can enhance your understanding of these key concepts of antagonism by working
									through a
									series of Questions (see Questions window) that encourage the use of the
									Dose-Response Visualiser
									(see the ‘Question’ window). An Answer to each of the Questions posed can be
									obtained by clicking
									on the Reveal Answer icon.
								</p>
							</div>
						</div>
						<div id="quant" class="container tab-pane">
							<div class="col col-lg-12">
								<p>
									Schild analyses enable the determination of the affinity (K<sub>B</sub>) of a
									competitive antagonist at a
									particular receptor that is mediating the response produced by an agonist. Thus, the
									Schild analysis
									is a particularly powerful approach for classifying and identifying the functional
									roles played by
									various receptor subtypes.
								</p>
								<p>
									As shown in the Dose-Response Visualiser, competitive antagonists produce a
									parallel, rightward
									shift of the agonist dose-response curve with no reduction in the maximum
									agonist-induced effect.
									The magnitude of the rightward shift increases as the [competitive antagonist]
									increases, and the
									magnitude of the shift (Dose Ratio) can be used to measure the affinity of the
									competitive
									antagonist for the receptor (Schild analysis). The Schild Plot plots the
									–log[antagonist] (M) on the x-
									axis against the calculated log(DR-1) on the y-axis (as can be seen in the Schild
									Plot window).
								</p>
								<p>
									If certain conditions are met (linearity, unity of slope), then a Schild Plot can be
									used to generate a
									pA<sub>2</sub> value, which is an estimate of the affinity of the competitive
									antagonist (K<sub>B</sub> value) for the
									receptor through which the agonist is producing the response. The pA<sub>2</sub> is
									determined by measuring
									the value of the dose ratio (DR) at several antagonist concentrations, allowing an
									estimate of the
									antagonist concentration at which log(DR-1) is zero.
								</p>
								<p>
									The calculated –logK<sub>B</sub> value of the antagonist can then be compared to
									known –logK<sub>i</sub> values of the
									antagonist obtained from the binding of the antagonist to pure populations of
									receptor subtypes,
									and through a process of elimination (incorporating the SPIKES approach), the
									receptor mediating
									the agonist-induced response identified.
								</p>
								<p>
									<b><i>In the Schild Plot Generator</i></b> you can choose the characteristics of the
									agonist (affinity, intrinsic
									efficacy) and cell (receptor density, coupling efficiency) by moving the red sliders
									along the grey
									bar (as per Dose-Response Visualiser). Furthermore, you can select the affinity of
									the antagonist (in
									the Competitive Antagonist window) and select up to three [antagonist] (in the
									Schild Plot Analysis
									window) for use in the Schild Analysis, by entering specific values or by using the
									up/down arrows.
									The Schild Plot Generator determines the [Agonist] that produces 50%Emax for each
									agonist dose-
									response curve to calculate the dose ratio and log(DR-1) values, which are presented
									within the
									Schild Analysis Table. The log(DR-1) values for the 3 [antagonist] are then plotted
									to generate the
									idealised Schild Plot. Any of the agonist, cell of antagonist parameters can be
									changed at any time
									and the effect on the Schild plot shown in real time. A return to default parameter
									values can be
									accomplished by clicking on the <b>RESET</b> button.
								</p>
								<p>
									You can enhance your understanding of the key concepts surrounding the theoretical
									and practical
									aspects of Schild Analysis by working through a series of Questions (see Questions
									window) that
									encourage the use of the Schild Plot Generator and the Reference Table of
									‘-logK<sub>i</sub> values’. An Answer
									to each of the Questions posed can be obtained by clicking on the Reveal Answer
									icon. Completing these
									questions, together with an understanding of the SPIKES approach to interpreting
									Schild plot data,
									will prepare you well for the ‘Schild Plot Analysis Quiz’.
								</p>
							</div>
						</div>
						<div id="quizz" class="container tab-pane">
							<div class="col col-lg-12">
								<p>
									The ‘Schild Plot Analysis Quiz’ presents you with a series of Schild Plots obtained
									to 5 antagonists
									acting on a single receptor subtype within a common cell. The challenge is to
									analyse each of the
									Schild Plots to deduce which single receptor subtype is mediating the
									agonist-induced response.
								</p>
								<p>
									A key factor in determining which receptor subtype is mediating the response is the
									application of
									the SPIKES approach. SPIKES is a mnemonic that provides a stepwise approach for
									analysing Schild
									plots.
								</p>
								<p>
									<span style="color:red; font-size: 22px"><b>S</b></span>hape of the Schild Plot –
									should be linear. Nonlinearity is indicative of key assumptions of the
									Schild Analysis not being met (e.g. antagonism must be competitive) and makes the
									pA<sub>2</sub> values
									potentially unreliable for K<sub>B</sub> determination. In the Quiz, analyse the
									shape of each Schild plot and
									select from the drop-down options (linear, nonlinear up, nonlinear down) the most
									appropriate
									description of the shape of the Schild Plot.
								</p>
								<p>
									<span style="color:red; font-size: 22px"><b>P</b></span>osition of the Schild Plot
									provides the pA<sub>2</sub> value – i.e. x-axis intercept. If the pA<sub>2</sub> is
									derived from a
									linear Schild plot with slope not significantly different from 1.0, then it can be
									converted to K<sub>B</sub> and be
									a true measure of the affinity of the antagonist for the receptor mediating the
									agonist-induced
									response. In the Quiz, enter the numerical value of the pA<sub>2</sub> for each
									antagonist.
								</p>
								<p>
									<span style="color:red; font-size: 22px"><b>I</b></span>nclination of the Schild
									Plot = slope of the Schild Plot, and should not be significantly different from
									value of 1.0. If slope &lt; 1, pA<sub>2</sub> is over-estimated &amp; if slope &gt;
									1, then pA<sub>2</sub> value is under-estimated. In
									the Quiz, determine the slope and select from the drop-down options (Slope=1,
									Slope&lt;1, Slope&gt;1,
									unsure) the most appropriate description of the slope for each antagonist Schild
									Plot.
								</p>
								<p>
									<span style="color:red; font-size: 22px"><b>K</b></span><sub>B</sub> is the antilog
									of the pA<sub>2</sub> and is a direct measure of the affinity of the antagonist for
									the receptor
									mediating the agonist-induce response. The K<sub>B</sub> value can be reliably
									derived from pA<sub>2</sub> only if the
									Schild plot is linear with unit slope. In the Quiz, determine whether the
									K<sub>B</sub> value can be reliably
									obtained from the pA<sub>2</sub> value (based on the prior analysis of Shape
									(linear) and Inclination (slope=1)
									of each Schild plot) by selecting the appropriate response from the drop-down list
									(Yes, No, Unsure).
								</p>
								<p>
									<span style="color:red; font-size: 22px"><b>E</b></span>limination. If for any
									antagonist, there is at least a 1.0 log unit difference between the observed
									pA<sub>2</sub> value and the known –logK<sub>i</sub> value at any particular
									receptor subtype (see reference Table of
									–logK<sub>i</sub> values), then that receptor subtype is unlikely to have mediated
									the agonist-induced response
									and can be eliminated from further analysis. In the Quiz, for each antagonist check
									the receptor box
									to indicate that that receptor has been eliminated.
								</p>
								<p>
									<span style="color:red; font-size: 22px"><b>S</b></span>ummation. In the Elimination
									process, each different antagonist is likely to have been able to
									eliminate one or more receptor subtypes as having mediated the agonist-induced
									response. By using
									the information obtained by using ALL the antagonists, a concerted process of
									elimination should
									leave just one receptor subtype as having mediated the response induced by the
									agonist. All
									obtained pA<sub>2</sub> values should be close to the –logK<sub>i</sub> values for
									the sole non-eliminated receptor. In the
									Quiz, in the ‘Your Solution’ window select the sole receptor subtype that is
									mediating the response.
								</p>
								<p>
									An additional feature of the Quiz is the inclusion of a hypothetical antagonist
									called Ant3311. The
									Schild plot for Ant3311 will not satisfy the requirements of linearity and/or unity
									of slope. In the
									Quiz, based on your analysis of the Ant3311 Schild plot and your understanding of
									why Schild plots
									may be nonlinear and/or have an slope different from 1.0, enter the most appropriate
									description of
									why Ant3311 Schild Plot is not ideal from the drop-down options (Ant3311 acts
									allosterically,
									Ant3311 acts irreversibly, high [Ant3311] are toxic, Ant3311 is a substrate of a
									saturable uptake
									process). To submit all your answers, click on the ‘Submit Answers’ button. This
									will take you to a
									new page that will indicate whether your submitted Solution was correct or
									incorrect. You have the
									option of ‘Amend your answers’ or to start a ‘New Quiz’.
								</p>
							</div>
						</div>
					</div>
					<div class="modal-footer">
						<button type="button" class="btn waves-effect waves-light red"
							data-dismiss="modal">Close</button>
					</div>
				</div>
			</div>
		</div>
		<div id="contact" class="modal fade" role="dialog">
			<div class="modal-dialog">
				<div class="modal-content">
					<div class="modal-header">
						<h4 class="modal-title">Contact</h4>
					</div>
					<div class="modal-body">
						<p>Is something not working properly?<br />Have an idea about how can we improve the interactive
							tools?<br />Please
							contact us!</p>
						<div class="box">
							<p class="contact"><b>Peter Henry</b><br />Associate Professor<br />The University of
								Western Australia</p>
							<p class="contact">Room 1.34, M Block,<br>School of Biomedical Sciences,<br>QEII Medical
								Centre</p>
							<p class="contact"><a
									href="mailto:peter.henry@uwa.edu.au?Subject=SPIKESfunc%20feedback">peter.henry@uwa.edu.au</a>
							</p>

						</div>
					</div>
					<div class="modal-footer">
						<button type="button" class="btn waves-effect waves-light red"
							data-dismiss="modal">Close</button>
					</div>
				</div>
			</div>
		</div>
	</footer>
</body>

</html>